Cambridge Cognition Holdings Stock

Cambridge Cognition Holdings ROCE 2024

Cambridge Cognition Holdings ROCE

0

Ticker

COG.L

ISIN

GB00B8DV9647

WKN

A1T9LW

In 2024, Cambridge Cognition Holdings's return on capital employed (ROCE) was 0, a -100% increase from the -1.38 ROCE in the previous year.

Cambridge Cognition Holdings Aktienanalyse

What does Cambridge Cognition Holdings do?

Cambridge Cognition Holdings PLC is a British company specializing in the development of computer programs for cognitive assessment of patients in medical research and development. The company was founded in 1986 by a group of neuroscientists from the University of Cambridge, who aimed to conduct neuropsychological research in standardized and automated form. The development of tests that could be conducted on computers was intended to increase the accuracy and efficiency of neuropsychological assessment of patients. The business quickly grew into a successful company, and Cambridge Cognition Holdings PLC was listed on the London Stock Exchange in 2013. The core business of the company is to provide tests and tools for assessing the cognitive functions of patients in medical research and development. Cambridge Cognition's products and services can be divided into two main categories: cognitive tests and digital therapeutic interventions. Cambridge Cognition's cognitive tests include a variety of specialized tests designed to assess the cognitive functions of patients. These tests cover areas such as memory, attention, executive function, and fine motor skills. The tests can be conducted on desktop computers, tablets, or mobile devices, offering standardization, efficiency, and reproducibility in the assessment of patients' cognitive functions. Another branch of the company is the development of digital therapeutic interventions. These interventions are designed to improve or maintain the cognitive functions of patients by triggering specific brain activities. An example of this is the "CogniFit" program for improving the cognitive abilities of older people. By using computer-based tests, the program aims to enhance users' cognitive functions and help slow down cognitive decline in old age. Cambridge Cognition Holdings PLC is not only involved in medical research but also in the pharmaceutical industry. The company offers services to pharmaceutical companies for conducting clinical studies testing the effectiveness of new drugs on cognitive functions. The combination of Cambridge Cognition's cognitive tests with clinical research provides an accurate assessment of the impact of medications on patients' cognitive functions. Cambridge Cognition's business model is based on the development and marketing of cognitive tests and digital therapeutic interventions. The company collaborates with medical research and development departments of pharmaceutical companies, academic institutions, and clinics. It also provides services related to clinical research to evaluate the effectiveness of new drugs on cognitive functions. Overall, Cambridge Cognition Holdings PLC is a leading company in medical research and development. Through the development of cognitive tests and digital therapeutic interventions, the company can contribute to improving patients' cognitive functions and accelerate the development of new medical therapies. Cambridge Cognition Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cambridge Cognition Holdings's Return on Capital Employed (ROCE)

Cambridge Cognition Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cambridge Cognition Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cambridge Cognition Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cambridge Cognition Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cambridge Cognition Holdings stock

What is the ROCE (Return on Capital Employed) of Cambridge Cognition Holdings this year?

The ROCE of Cambridge Cognition Holdings is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of Cambridge Cognition Holdings developed compared to the previous year?

The ROCE of Cambridge Cognition Holdings has increased by -100% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cambridge Cognition Holdings?

A high Return on Capital Employed (ROCE) indicates that Cambridge Cognition Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cambridge Cognition Holdings?

A low ROCE (Return on Capital Employed) can indicate that Cambridge Cognition Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cambridge Cognition Holdings impact the company?

An increase in the ROCE of Cambridge Cognition Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cambridge Cognition Holdings affect the company?

A decrease in ROCE of Cambridge Cognition Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cambridge Cognition Holdings?

Some factors that can affect Cambridge Cognition Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cambridge Cognition Holdings so important for investors?

The ROCE of Cambridge Cognition Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cambridge Cognition Holdings take to improve the ROCE?

To improve the ROCE, Cambridge Cognition Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cambridge Cognition Holdings pay?

Over the past 12 months, Cambridge Cognition Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Cognition Holdings is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Cognition Holdings?

The current dividend yield of Cambridge Cognition Holdings is .

When does Cambridge Cognition Holdings pay dividends?

Cambridge Cognition Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Cognition Holdings?

Cambridge Cognition Holdings paid dividends every year for the past 0 years.

What is the dividend of Cambridge Cognition Holdings?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Cognition Holdings located?

Cambridge Cognition Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Cognition Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Cognition Holdings from 8/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 8/31/2024.

When did Cambridge Cognition Holdings pay the last dividend?

The last dividend was paid out on 8/31/2024.

What was the dividend of Cambridge Cognition Holdings in the year 2023?

In the year 2023, Cambridge Cognition Holdings distributed 0 GBP as dividends.

In which currency does Cambridge Cognition Holdings pay out the dividend?

The dividends of Cambridge Cognition Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cambridge Cognition Holdings

Our stock analysis for Cambridge Cognition Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cambridge Cognition Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.